Skip to main content
SpringerLink
Log in

Effect of the proteasome inhibitor MLN519 on the expression of inflammatory molecules following middle cerebral artery occlusion and reperfusion in the rat

  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

Abstract

Anti-inflammatory treatment with the proteasome inhibitor MLN519 has been previously reported to be neuroprotective against ischemic brain injury in rats. These effects have been related to inhibition of the transcription factor NF-κB, which is activated through ubiquitin-proteasomal degradation. The aim of this study was to evaluate the effects of MLN519 to alter the expression of several inflammatory genes under the control of NF-κB. Male Sprague-Dawley rats underwent middle cerebral artery occlusion (MCAo) followed by vehicle or MLN519 (1.0 mg/kg, i.v.) treatment immediately after reperfusion of blood to the brain at 2h. Gene expression was evaluated 3–72 h post-MCAo. The most striking effects of intravenous treatment with MLN519 were associated with reductions in ICAM-1 expression at 3 h followed by reductions in E-selectin (12–72 h). Less dramatic reductions were observed in IL-1β (3–24h) and TNF-α (24 h) with no apparent effects on IL-6 and VCAM-1 mRNA levels. Immunohistochemical analysis revealed that the genes most dramatically affected by MLN519 had highest expression in endothelial cells and leukocytes (E-selectin, ICAM-1), indicating that these cell types may be the primary targets of intravenously delivered MLN519 treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abraham E (2000) NF-κB activation.Crit. Care Med. 28, N100-N104.

    Article  PubMed  CAS  Google Scholar 

  • Ali C, O Nicole, F Docagne, S Lesne, ET MacKenzie, A Nouvelot, A Buisson and D Vivien (2000) Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain.J. Cereb. Blood Flow Metab. 20, 956–966.

    PubMed  CAS  Google Scholar 

  • Baeuerle PA and D Baltimore (1988) I κ B: a specific inhibitor of the NF-κ B transcription factor.Science 242, 540–546.

    Article  PubMed  CAS  Google Scholar 

  • Barone FC, DB Schmidt, LM Hillegass, WJ Price, RF White, GZ Feuerstein, RK Clark, EV Lee, DE Griswold and HM Sarau (1992) Reperfusion increases neutrophils and leukotriene B4 receptor binding in rat focal ischemia.Stroke 23, 1337–1347; discussion 1347–8.

    PubMed  CAS  Google Scholar 

  • Beg AA, SM Ruben, RL Scheinman, S Haskill, CA Rosen and AS Baldwin Jr (1992) I κB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention.Genes Dev. 6, 1899–1913.

    Article  PubMed  CAS  Google Scholar 

  • Berti R, A Williams, J Moffett, S Hale, L Velarde, P Elliott, C Yao, J Dave and F Tortella (2002) Quantitative real time PCR mRNA analysis of the inflammatory cascade associated with ischemia reperfusion brain injury.J. Cereb. Blood Flow Metab. 22, 1068–1079.

    Article  PubMed  CAS  Google Scholar 

  • Boutin H, RA LeFeuvre, R Horai, M Asano, Y Iwakura and NJ Rothwell (2001) Role of IL-1α and IL-1β in ischemic brain damage.J. Neurosci. 21, 5528–5534.

    PubMed  CAS  Google Scholar 

  • Brand K, S Page, G Rogler, A Bartsch, R Brandl, R Knuechel, M Page, C Kaltschmidt, PA Baeuerle and D Neumeier (1996) Activated transcription factor nuclear factor-κ B is present in the atherosclerotic lesion.J. Clin. Invest. 97, 1715–1722.

    Article  PubMed  CAS  Google Scholar 

  • Bullard DC, ET Sandberg, K Scharffetter-Kochanek and AL Beaudet (1995) Gene targeting for inflammatory cell adhesion molecules.Agents Actions Suppl. 47, 143–154.

    PubMed  CAS  Google Scholar 

  • Elliott P and J Ross (2001) The proteasome: a new target for novel drug therapies.Am. J. Clin. Pathol. 116, 637–646.

    Article  PubMed  CAS  Google Scholar 

  • Emerich DF, RL Dean 3rd and RT Bartus (2002) The role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct?Exp. Neurol. 173, 168–181.

    Article  PubMed  Google Scholar 

  • Feuerstein GZ, T Liu and FC Barone (1994) Cytokines, inflammation, and brain injury: role of tumor necrosis factor-α.Cerebrovasc. Brain Metab. Rev. 6, 341–360.

    PubMed  CAS  Google Scholar 

  • Frijns CJ and LJ Kappelle (2002) Inflammatory cell adhesion molecules in ischemic cerebrovascular disease.Stroke 33, 2115–2122.

    Article  PubMed  CAS  Google Scholar 

  • Hill W, D Hess, J Carroll, G Chandramohan, E Howard, Q Chen, C Cheng, A Martin-Studdard, J Waller and R Beswick (2001) The NF-κB inhibitor diethyldithiocarbamate (DDTC) increases brain cell death in a transient middle cerebral artery occlusion model of ischemia.Brain Res. Bull. 55, 375–386.

    Article  PubMed  CAS  Google Scholar 

  • Li X and X Wang (2000) Application of real-time polymerase chain reaction for the quantitation of interleukin-1β mRNA upregulation in brain ischemic tolerance.Brain Res. Brain Res. Protoc. 5, 211–217.

    Article  PubMed  CAS  Google Scholar 

  • Martin-Villalba A, M Hahne, S Kleber, J Vogel, W Falk, J Schenkel and PH Krammer (2001) Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke.Cell Death Differ. 8, 679–686.

    Article  PubMed  CAS  Google Scholar 

  • Morikawa E, SM Zhang, Y Seko, T Toyoda and T Kirino (1996) Treatment of focal cerebral ischemia with synthetic oligopeptide corresponding to lectin domain of selectin.Stroke 27, 951–955: discussion 956.

    PubMed  CAS  Google Scholar 

  • Nonaka M, XH Chen, JE Pierce, MJ Leoni, TK McIntosh, JA Wolf and DH Smith (1999) Prolonged activation of NF-κB following traumatic brain injury in rats.J. Neurotrauma 16, 1023–1034.

    Article  PubMed  CAS  Google Scholar 

  • Phillips J, A Williams, J Adams, P Elliott and F Tortella (2000) Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia.Stroke 31, 1686–1693.

    PubMed  CAS  Google Scholar 

  • Schielke GP, GY Yang, BD Shivers and AL Betz (1998) Reduced ischemic brain injury in interleukin-1β converting enzyme-deficient mice.J. Cereb. Blood Flow Metab. 18, 180–185.

    Article  PubMed  CAS  Google Scholar 

  • Shah IM, KR Lees, CP Pien and PJ Elliot (2002) Early clinical experience with the novel proteasome inhibitor PS-519. J.Clin. Pharmacol. 54, 269–276.

    Article  CAS  Google Scholar 

  • Stroemer RP, TA Kent and CE Hulseboseh (1995) Neocortical neural sprouting, synaptogenesis, and behavioral recovery after neocortical infarction in rats.Stroke 26, 2135–2144.

    PubMed  CAS  Google Scholar 

  • Stromer RP and NJ Rothwell (1998) Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1β in the rat.J. Cereb. Blood Flow Metab. 18, 833–839.

    Article  Google Scholar 

  • Tak PP and GS Firestein (2001) NF-κB: a key role in inflammatory diseases.J. Clin. Invest. 107, 7–11.

    Article  PubMed  CAS  Google Scholar 

  • Takeda H, M Spatz, C Ruetzler, R McCarron, K Becker, and E Hallenbeck (2002) Induction of mucosal tolerance to E-selectin prevents ischemic and hemorrhagic stroke in spontaneously hypertensive genetically stroke- prone rats.Stroke 33, 2156–2164.

    Article  PubMed  CAS  Google Scholar 

  • Toyoda T, N Kassell and K Lee (1997) Induction of ischemic tolerance and antioxidant activity by brief focal ischemia.Neuroreport 8, 847–851.

    Article  PubMed  CAS  Google Scholar 

  • Verma IM, JK Stevenson, EM Schwarz, D Van Antwerp and S Miyamoto (1995) Rel/NF-κB/I κB family: intimate tales of association and dissociation.Genes Dev. 9, 2723–2735.

    Article  PubMed  CAS  Google Scholar 

  • Wang X, X Li, R Currie, R Willette, F Barone and G Feuerstein (2000a) Application of real-time polymerase chain reaction to quantitate induced expression of interleukin-1beta mRNA in ischemic brain tolerance.J. Neurosci. Res. 59, 238–246.

    Article  PubMed  CAS  Google Scholar 

  • Wang X, X Li, JA Erhardt, FC Barone and GZ Feuerstein (2000b) Detection of tumor necrosis factor-α mRNA induction in ischemic brain tolerance by means of real-time polymerase chain reaction.J. Cereb. Blood Flow Metab. 20, 15–20.

    Article  PubMed  Google Scholar 

  • Wang X, TL Yue, FC Barone and GZ Feuerstein (1995a) Demonstration of increased endothelial-leukocyte adhesion molecule-1 mRNA expression in rat ischemic cortex.Stroke 26, 1665–1668; discussion 1668.

    PubMed  CAS  Google Scholar 

  • Wang X, TL Yue, PR Young, FC Barone and GZ Feuerstein (1995b) Expression of interleukin-6, c-fos, and zif268 mRNAs in rat ischemic cortex.J. Cereb. Blood Flow Metab. 15, 166–171.

    PubMed  CAS  Google Scholar 

  • Williams A, J Dave, J Phillips, Y Lin, R McCabe and F Tortella (2000) Neuroprotective efficacy and therapeutic window of the high-affinityN-methyl-d-aspartate antagonist conantokin-G:in vitro (primary cerebellar neurons) andin vivo (rat model of transient focal brain ischemia) studies.J. Pharmacol. Exp. Ther. 294, 378–386.

    PubMed  CAS  Google Scholar 

  • Williams AJ, SL Hale, JR Moffett, JR Dave, PJ Elliott, J Adams and FC Tortella (2003) Delayed treatment with MLN519 reduces infarction and associated neurologic deficit caused by focal ischemic brain injury in rats via antiinflammatory mechanisms involving nuclear factor-κB activation, gliosis, and leukocyte infiltration.J. Cereb. Blood Flow Metab. 23, 75–87.

    Article  PubMed  CAS  Google Scholar 

  • Yamasaki Y, H Shozuhara, H Onodera and K Kogure (1994) Blocking of interleukin-1 activity is a beneficial approach to ischemia brain edema formation.Acta. Neurochir. Suppl. 60, 300–302.

    CAS  Google Scholar 

  • Yang GY, C Gong, Z Qin, W Ye, Y Mao, and AL Bertz (1998) Inhibition of TNFα attenuates infarct volume and ICAM-1 expression in ischemic mouse brain.Neuroreport 9, 2131–2134.

    Article  PubMed  CAS  Google Scholar 

  • Yao C, A Williams, P Cui, R Berti, J Hunter, F Tortella and J Dave (2002) Differential pattern of expression of voltage-gated sodium channel genes following ischemic brain injury in rats.Neurotoxicity Res. 4, 67–75.

    Article  CAS  Google Scholar 

  • Yao C, AJ Williams, X-CM Lu, RA Price, BS Cunningham, R Berti, FC Tortella and JR Dave (2003) The sodium channel blocker RS100642 reverses down-regulation of the sodium channel α-subunit Nav 1.1 expression caused by transient ischemic brain in jury in rats.Neurotoxicity Res. 5(4), 245–254.

    Article  CAS  Google Scholar 

  • Yoshimoto T, K Houkin, M Tada and H Abe (1997) Induction of cytokines, chemokines and adhesion molecule mRNA in a rat forebrain reperfusion model.Acta. Neuropathol. (Berl.) 93, 154–158.

    Article  CAS  Google Scholar 

  • Zhai QH, N Futrell and FJ Chen (1997) Gene expression of IL-10 in relationship to TNF-α, IL-1β and IL-2 in the rat brain following middle cerebral artery occlusion.J. Neurol. Sci. 152, 119–124.

    Article  PubMed  CAS  Google Scholar 

  • Zhang L, Z Zhang, R Zhang, M Lu, J Adams, P Elliott and M Chopp (2001) Postischemic (6-Hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia.Stroke 32, 2926–2931.

    Article  PubMed  CAS  Google Scholar 

  • Zhang RL, M Chopp, Y Li, C Zaloga, N Jiang, ML Jones, M Miykasaka and PA Ward (1994) Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat.Neurology 44, 1747–1751.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neurosciences, Walter Reed Army Institute of Research, 20910, Silver Spring, MD, USA

    R. Berti, A. J. Williams, L. C. Velarde, J. R. Moffett, C. Yao, J. R. Dave & F. C. Tortella

  2. Combinato RX, Inc, Boston, MA, USA

    P. J. Elliott

  3. Millenium Pharm., Cambridge, MA, USA

    J. Adams

Authors
  1. R. Berti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. J. Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. C. Velarde
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. R. Moffett
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. J. Elliott
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Adams
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. Yao
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J. R. Dave
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. F. C. Tortella
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. R. Dave.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berti, R., Williams, A.J., Velarde, L.C. et al. Effect of the proteasome inhibitor MLN519 on the expression of inflammatory molecules following middle cerebral artery occlusion and reperfusion in the rat. neurotox res 5, 505–514 (2003). https://doi.org/10.1007/BF03033160

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03033160

Keywords

Search

Navigation